In 2006, Asia Pacific contributed to 7.0 percent of the total market share and this is expected to increase as the Asia Pacific market displays an upward trend in growth. The increased share of contribution from Asia Pacific countries is expected to be fuelled by the expiry of patents and limited pipeline of blockbuster drugs. This opens up opportunity for developing nations to strengthen their local pharmaceutical industries by entering the arena of generics and traditional medicine